Category: Drug industry

2 7/27/2015

Fred Hutch president predicts cancer cure in 10 years; critics have heard it all before

7/24/2015

Taking stock of new Alzheimer’s drug coverage: A “landmark breakthrough” that offers no “clinically apparent benefit”

6/30/2015

Harvard’s Jerry Avorn warns against FDA loosening off-label marketing restrictions

4 6/25/2015

Vyvanse – A life cycle drug? Or disease mongering?

10 6/5/2015

Astroturfers rule the day: FDA’s flibanserin reviewers were “emotionally blackmailed” by a slick lobbying campaign

3 6/3/2015

Pink Viagra may be coming soon (but for teetotalers, only!)

6/3/2015

Former NEJM editors slam “backtrack” on conflict of interest

1 6/2/2015

NEJM reignites conflict-of-interest debate with reader poll

4 5/21/2015

Responding to parts 2-3 of New England Journal of Medicine’s series on pharma-MD relations

6 5/14/2015

Criticism of NEJM’s defense of industry-physician relations